Concert Pharmaceuticals Reports First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall St futures decline as US-Iran escalation rattles sentiment
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 3% as fresh military strikes threaten Hormuz shipments
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- The real reason Meta shares are surging has nothing to do with its new AI model
Concert Pharma (CNCE) Tops Q1 EPS by 39c
May 3, 2018 7:27 AM EDTConcert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($0.19), $0.39 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $10.5 thousand versus the consensus estimate of $10 thousand.
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
... More